SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after reporting a strong Q4 earnings beat, achieving its first full year of GAAP profitability, and authorizing a $500 million stock buyback, fueling community debate between those anticipating a short squeeze and others concerned about modest growth guidance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as rising geopolitical tensions in the Middle East, impacting oil supply and prices, coupled with new trade probes, create market uncertainty. The community is debating if the current weakness signals a looming correction or if past resilience and "buy the dip" strategies will continue to defy negative macro headwinds.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

IXHL is trending as it nears NASDAQ compliance and anticipation builds for End-of-Phase 2 results for its fast-tracked sleep apnea drug, IHL-42X. The community sees significant undervaluation and potential for a massive rally, tempered by ongoing discussions about the CEO's dilution history.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to its new collaboration with Novo Nordisk and the dismissal of their lawsuit, solidifying its position in the lucrative GLP-1 market. The community is actively discussing a short squeeze, fueled by high short interest and robust trading volume, as the stock demonstrates significant resilience even during broader market downturns.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic (LWLG) is buzzing following its development agreement with Tower Semiconductor, which investors view as a pivotal step towards integrating its high-performance electro-optic polymers into next-gen silicon photonics, with community speculation pointing to future collaborations with major AI chipmakers.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending amid an imminent mainnet launch for its Goliath blockchain, which aims to establish real-world asset tokenization and global payment rails, coupled with recent international expansion efforts. Community sentiment is sharply divided, with strong bullish anticipation for this development countered by significant skepticism and warnings of potential 'sell the news' price action and historical market manipulation.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

Anticipation is exceptionally high for New Era Energy's imminent announcement of a major hyperscaler tenant for its Texas Critical Data Centers, with recent land acquisitions further highlighting its strategic position in providing integrated power for the booming AI data center sector. While many investors remain bullish on the potential for a significant short squeeze, community discussions reflect a mix of confidence and growing frustration over the timing of the awaited tenant news.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency &lt;1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

HYPE is trending as the Hyperliquid platform showcases strong performance with high transaction volumes and new developments, like its predictions market, fueling community discussion around its growing utility in decentralized perpetual trading and deflationary tokenomics.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is gaining significant attention following the successful Alpha Flight 7 mission, which successfully deployed a Lockheed Martin payload, and its recent inclusion in the substantial SHIELD "Golden Dome" defense contract, driving community optimism for its expanding role in the space and defense sectors.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is currently trending as community members are actively accumulating the decentralized storage token amidst recent dips, with discussions highlighting its pivotal role in the burgeoning AI and DePIN sectors. The network's core utility, recent upgrades impacting gas fees, and growing partnerships are fueling optimism for its long-term potential as critical infrastructure for Web3.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$WVE Paul, hurry up! 
 
Lilly to Invest $3 Billion in China to Boost Obesity Pill 
By Amber Tong   March 11, 2026 
 
Eli Lilly &amp; Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity market. 
https://www.bloomberg.com/news/articles/2026-03-11/lilly-to-invest-3-billion-in-china-to-boost-obesity-pill 
 
Ascletis eyes quarterly GLP-1 dosing following phase 2 obesity readout 
By Nick Paul Taylor  Mar 10, 2026 
https://www.fiercebiotech.com/biotech/ascletis-posts-phase-2-obesity-data-touts-potential-quarterly-glp-1-dosing

Steven Craig

Ascletis posted phase 2 data on its ultra-long-acting GLP-1, generating early evidence that the formulation may support quarterly maintenance dosing.

Fierce Biotech

Ascletis eyes quarterly GLP-1 dosing following phase 2 obesity readout

$WVE Wave must act quickly to secure a partner or buyer, as competitors are not standing still. Remaining standalone is not an option. Most biotech “startups” are designed to be acquired by Big Pharma rather than to become standalone pharmaceutical companies. 
 
Pfizer Secures China Nod for Obesity Drug as Generics Loom 
By Amber Tong   March 6, 2026  
https://www.bloomberg.com/news/articles/2026-03-06/pfizer-secures-china-nod-for-obesity-drug-as-generics-loom 
 
Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026 
Mar 05, 2026 
Neurizon reported new ASENT 2026 preclinical data showing NUZ-001 and its active metabolite are biologically active in Huntington’s disease models, with disease-dependent restoration of BDNF and enhanced autophagic markers. 
… 
https://www.tipranks.com/news/company-announcements/neurizon-expands-nuz-001-huntingtons-disease-data-at-asent-2026

StockTwits Web

Wave Life Sciences Ltd

Big Believer

 Paul, hurry up! 
 
Lilly to Invest $3 Billion in China to Boost Obesity Pill 
By Amber Tong   March 11, 2026 
 
Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity market. 


 
 
Ascletis eyes quarterly GLP-1 dosing following phase 2 obesity readout 
By Nick Paul Taylor  Mar 10, 2026 
